{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:14:20Z","timestamp":1777331660599,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010643","name":"Cidara Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dmd.2025.100103","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:01:11Z","timestamp":1748001671000},"page":"100103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat"],"prefix":"10.1016","volume":"53","author":[{"given":"Aline","family":"Laenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-9301","authenticated-orcid":false,"given":"Shawn","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4960-2811","authenticated-orcid":false,"given":"Grayson","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3420-424X","authenticated-orcid":false,"given":"Jan","family":"Snoeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Cuyckens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Mannens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-6717","authenticated-orcid":false,"given":"Voon","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100103_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19420862.2015.1008353","article-title":"The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity","volume":"7","author":"Abdiche","year":"2015","journal-title":"MAbs"},{"issue":"Suppl 1","key":"10.1016\/j.dmd.2025.100103_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","article-title":"Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers","volume":"36","author":"Cass","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100103_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.535","article-title":"The pharmacology and therapeutic applications of monoclonal antibodies","volume":"7","author":"Castelli","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.dmd.2025.100103_bib4","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall\u2019Acqua","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2025.100103_bib5","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.169.9.5171","article-title":"Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences","volume":"169","author":"Dall\u2019Acqua","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.dmd.2025.100103_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41564-025-01955-3","article-title":"Drug\u2013Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice","volume":"10","author":"D\u00f6hrmann","year":"2025","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.dmd.2025.100103_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/v11050458","article-title":"Competitive cooperation of hemagglutinin and neuraminidase during influenza A virus entry","volume":"11","author":"Du","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.dmd.2025.100103_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical pharmacokinetics of therapeutic monoclonal antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100103_bib9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics","volume":"93","author":"Lobo","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100103_bib10","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/jm040891b","article-title":"Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza","volume":"48","author":"Macdonald","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.dmd.2025.100103_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"McAuley","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.dmd.2025.100103_bib12","article-title":"Comparison of different allometric scaling approaches to project human PK of CD388, a novel drug-Fc conjugate in development for influenza prevention. Poster 5298","author":"Ong","year":"2024","journal-title":"ASM Microbe"},{"key":"10.1016\/j.dmd.2025.100103_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cts.12567","article-title":"Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development","volume":"11","author":"Ovacik","year":"2018","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmd.2025.100103_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of monoclonal antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.dmd.2025.100103_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-2952(62)90007-2","article-title":"Autoradiographic localization in the tissues of drugs and metabolites","volume":"9","author":"Ullberg","year":"1962","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100103_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jps.22338","article-title":"Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus","volume":"100","author":"Weight","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100103_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/jcm10061323","article-title":"Preclinical characterization of the distribution, catabolism, and elimination of a polatuzumab vedotin-piiq (POLIVY\u00ae) antibody\u2013drug conjugate in Sprague Dawley rats","volume":"10","author":"Yip","year":"2021","journal-title":"J Clin Med"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T10:09:02Z","timestamp":1753697342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0090955625091123"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100103","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100103"}}